Local biopharm firm makes headway on experimental product for premature infants with RDS

Windtree is developing the system to deliver a non-invasive treatment for respiratory distress syndrome in premature infants.

Source: bizjournals.com Health Care:Biotechnology headlines - August 7, 2018 Category: Biotechnology Authors: John George Source Type: news